Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immune Surveillance by NK Cells and Phagocytes

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Label-free multiphoton microscopy for intraoperative identification of glioma features and tumor heterogeneity.

Frontiers in oncology·2026

Same author

Clinical Implementation and Oncological Relevance of Molecular Profiling in Brain Metastases Patients-A Multicenter Retrospective Cohort Study.

International journal of cancer·2026

Same author

Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterations.

Journal of neuro-oncology·2026

Same author

Rethinking the role of surgery and radiotherapy in BRAF-mutant papillary craniopharyngioma: a position statement from the neurosurgical perspective.

Neurosurgical focus·2026

Same author

Retraction Notice to: Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Low Energy and Protein Intake in Brain Tumor Patients Despite Higher Adiposity: A Comparative Study with Gastrointestinal Cancer.

Nutrients·2026

Search research articles

Related Experiment Video

Updated: May 18, 2026

Phagosome Migration and Velocity Measured in Live Primary Human Macrophages Infected with HIV-1

Phagosome Migration and Velocity Measured in Live Primary Human Macrophages Infected with HIV-1

Published on: September 5, 2016

Brain miffed by macrophage migration inhibitory factor.

Nic E Savaskan¹, Günter Fingerle-Rowson, Michael Buchfelder

¹Department of Neurosurgery, University of Erlangen-Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany.

International Journal of Cell Biology

|September 14, 2012

Summary

Macrophage migration inhibitory factor (MIF) is a key mediator in immunity and inflammation. Targeting MIF offers potential therapeutic strategies for brain diseases, including neurodegenerative conditions and brain tumors.

More Related Videos

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry

Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry

Published on: June 22, 2017

Related Experiment Videos

Last Updated: May 18, 2026

Phagosome Migration and Velocity Measured in Live Primary Human Macrophages Infected with HIV-1

Phagosome Migration and Velocity Measured in Live Primary Human Macrophages Infected with HIV-1

Published on: September 5, 2016

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry

Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry

Published on: June 22, 2017

Area of Science:

Biochemistry
Immunology
Oncology

Background:

Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine with oxidoreductase and tautomerase activity.
MIF is integral to innate and acquired immunity, the neuroendocrine axis, and pathogenesis of inflammation, cancer, and neoangiogenesis.
MIF signaling is implicated in redox balance, apoptosis, senescence, and acts as a glucocorticoid antagonist, contributing to therapeutic resistance in brain tumors.

Purpose of the Study:

To review the multifaceted roles of MIF, particularly its redox regulation in apoptosis and tumor growth.
To explore the extracellular functions of MIF and its potential involvement in brain diseases.
To consider novel MIF-neutralizing approaches for therapeutic intervention in neurodegenerative diseases and brain tumors.

Main Methods:

Literature review of MIF's functions, signaling pathways, and therapeutic potential.
Analysis of MIF's involvement in redox regulation, apoptosis, and tumor growth.
Examination of MIF's extracellular roles and receptor-mediated pathways (CD74/CXCR2/CXCR4).

Main Results:

MIF regulates essential cellular systems including redox balance, HIF-1, and p53-mediated apoptosis and senescence.
MIF acts as an endogenous glucocorticoid antagonist, contributing to resistance in brain tumor therapies.
A functional homolog, D-dopachrome tautomerase/MIF-2, utilizes the same cell surface receptor signaling cascade as MIF.

Conclusions:

MIF is a relevant mediator in neurodegenerative and neurooncological diseases, though under-investigated.
Targeting MIF presents a promising therapeutic avenue for brain diseases, including neuroprotection and anti-cancer strategies.
Novel MIF-neutralizing approaches warrant further investigation for treating neurodegenerative processes and brain tumors.